← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.2M

Shares

40,472

Price

$30

Filed

Nov 26

Insider

Name

Krainer Adrian R.

Title

CIK

0001780081

Roles

Director

Transaction Details

Transaction Date

2025-11-24

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

323,774

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $30.12 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001780081-25-000006

Form Type

4

Issuer CIK

0001623526

Krainer Adrian R.'s History

Date Ticker Type Value
2025-11-24 STOK $1.2M
2025-11-14 STOK $527K
2025-11-14 STOK $565K
2025-06-03 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
SMITH IAN F
Chief Executive Officer
2026-02-17
Hoitt Jason
Chief Patient Officer
2026-02-17
Leggett Thomas
Chief Financial Officer
2026-02-17
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20